Comparison of human eosinophil and neutrophil adhesion to endothelial cells under nonstatic conditions. Role of L-selectin. 1994

E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224.

To simulate adhesion that occurs under conditions of flow, we investigated the attachment of eosinophils to endothelium under rotational conditions. Tissue-culture plates containing monolayers of HUVEC were placed on a horizontal rotator (80 revolutions per minute (rpm)), and equal numbers of purified human eosinophils or neutrophils were added to separate wells at 4 degrees C. Binding of eosinophils and neutrophils to unstimulated endothelial cells was 15 +/- 3 and 31 +/- 11 cells/four high power fields (HPF), respectively. After preincubation of HUVEC with IL-1 beta (1 ng/ml, 4 h, 37 degrees C), adhesion increased to 56 +/- 4 and 290 +/- 26 cells/four HPF, respectively (p < 0.0002 for both, n = 8-14). Eosinophils with reduced levels of L-selectin (blood eosinophils activated in vitro or eosinophils obtained from bronchoalveolar lavage (BAL) performed after segmental lung allergen challenge of allergic subjects) demonstrated reduced binding under rotating conditions. Several L-selectin Abs inhibited adhesion of eosinophils and neutrophils (e.g., LAM1-3: 43 +/- 14% vs 63 +/- 3% inhibition; LAM1-6: 73 +/- 5% vs 36 +/- 6% inhibition, respectively, n > or = 6). Interestingly, one additional L-selectin Ab, LAM1-11, inhibited eosinophil but not neutrophil adhesion (51 +/- 2% vs 1 +/- 7% inhibition, respectively, n > or = 5). We conclude that eosinophils, like neutrophils, use L-selectin to bind to activated endothelial cells under conditions of flow, although mAb LAM1-11 can selectively inhibit eosinophil attachment to stimulated endothelial cells in vitro, suggesting different functional epitopes on L-selectin among eosinophils and neutrophils.

UI MeSH Term Description Entries
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004804 Eosinophils Granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin. Eosinophil
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015815 Cell Adhesion Molecules Surface ligands, usually glycoproteins, that mediate cell-to-cell adhesion. Their functions include the assembly and interconnection of various vertebrate systems, as well as maintenance of tissue integration, wound healing, morphogenic movements, cellular migrations, and metastasis. Cell Adhesion Molecule,Intercellular Adhesion Molecule,Intercellular Adhesion Molecules,Leukocyte Adhesion Molecule,Leukocyte Adhesion Molecules,Saccharide-Mediated Cell Adhesion Molecules,Saccharide Mediated Cell Adhesion Molecules,Adhesion Molecule, Cell,Adhesion Molecule, Intercellular,Adhesion Molecule, Leukocyte,Adhesion Molecules, Cell,Adhesion Molecules, Intercellular,Adhesion Molecules, Leukocyte,Molecule, Cell Adhesion,Molecule, Intercellular Adhesion,Molecule, Leukocyte Adhesion,Molecules, Cell Adhesion,Molecules, Intercellular Adhesion,Molecules, Leukocyte Adhesion
D016177 Macrophage-1 Antigen An adhesion-promoting leukocyte surface membrane heterodimer. The alpha subunit consists of the CD11b ANTIGEN and the beta subunit the CD18 ANTIGEN. The antigen, which is an integrin, functions both as a receptor for complement 3 and in cell-cell and cell-substrate adhesive interactions. CR3 Receptor,Complement 3 Receptor,Integrin alphaMbeta2,Mac-1 Antigen,Receptor, Complement 3,Adhesive Receptor Mac-1,Integrin alpha(M)beta(2),Integrin alpha-M beta-2,Mac-1 Adhesive Receptor,Mac-1 Receptor,Mo1 Antigen Receptor,Mo1 Glycoprotein Receptor,Receptor, CR3,Receptor, Mo1 Antigen,Receptor, Mo1 Glycoprotein,Adhesive Receptor, Mac-1,Antigen Receptor, Mo1,Antigen, Macrophage-1,Glycoprotein Receptor, Mo1,Integrin alpha M beta 2,Mac 1 Adhesive Receptor,Mac 1 Antigen,Mac 1 Receptor,Macrophage 1 Antigen,Receptor, Mac-1 Adhesive,alpha-M beta-2, Integrin,alphaMbeta2, Integrin
D019041 L-Selectin Cell adhesion molecule and CD antigen that serves as a homing receptor for lymphocytes to lymph node high endothelial venules. Antigens, CD62L,CD62L Antigens,LECAM-1,CD62L Antigen,L Selectin,LAM-1,Leu-8 Antigen,Leukocyte Adhesion Molecule, LAM-1,Mel-14 Antigen,TQ1 Antigen,Antigen, CD62L,Antigen, Leu-8,Antigen, Mel-14,Antigen, TQ1,Leu 8 Antigen,Leukocyte Adhesion Molecule, LAM 1,Mel 14 Antigen,Selectin, L
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
January 1996, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
June 1992, The Journal of experimental medicine,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
September 2005, The Journal of experimental medicine,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
January 2001, Journal of immunology (Baltimore, Md. : 1950),
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
March 1997, Blood,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
May 1993, Blood,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
October 1997, Journal of immunology (Baltimore, Md. : 1950),
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
July 1996, Journal of immunology (Baltimore, Md. : 1950),
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
December 1995, Biochemical and biophysical research communications,
E F Knol, and F Tackey, and T F Tedder, and D A Klunk, and C A Bickel, and S A Sterbinsky, and B S Bochner
March 1999, Journal of leukocyte biology,
Copied contents to your clipboard!